We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.96B
AUM Growth
+$180M
(+3.8%)
Cap. Flow
+$9.65M
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
16.47%
Holding
683
New
65
Increased
262
Reduced
255
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$53M |
| 2 |
Johnson & Johnson
JNJ
|
+$42.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$27.6M |
| 4 |
PepsiCo
PEP
|
+$27.5M |
| 5 |
Mastercard
MA
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$32.8M |
| 2 |
ADT
ADT Corp
ADT
|
+$23.8M |
| 3 |
Cigna
CI
|
+$21.3M |
| 4 |
First Solar
FSLR
|
+$21.3M |
| 5 |
AET
Aetna Inc
AET
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.7% |
| 2 | Financials | 13.24% |
| 3 | Technology | 10.59% |
| 4 | Industrials | 7.94% |
| 5 | Consumer Discretionary | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bath & Body Works
BBWI
$4.01B
| $6.53M | 0.13% |
85,682
+72,309
| +541% | +$5.22M |
|
202
Teva Pharmaceuticals
TEVA
$35.9B
| $6.48M | 0.13% |
104,041
+28,340
| +37% | +$1.65M |
|
203
CMS Energy
CMS
$23.1B
| $6.44M | 0.13% |
184,526
+129,648
| +236% | +$4.6M |
|
|
MRO
204
DELISTED
Marathon Oil Corporation
MRO
| $6.41M | 0.13% |
245,429
-48,400
| -16% | -$1.31M |
|
205
Freeport-McMoran
FCX
$90B
| $6.4M | 0.13% |
337,714
-55,160
| -14% | -$1.09M |
|
206
Ameren
AEE
$31.5B
| $6.4M | 0.13% |
151,545
-82,344
| -35% | -$3.58M |
|
207
Ionis Pharmaceuticals
IONS
$9.35B
| $6.37M | 0.13% |
100,000
-50,000
| -33% | -$3.39M |
|
|
ISEE
208
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.33M | 0.13% |
136,000
| – | – |
|
209
United Therapeutics
UTHR
$26.3B
| $6.21M | 0.13% |
36,000
+7,000
| +24% | +$1.07M |
|
210
Monster Beverage
MNST
$91.4B
| $6.18M | 0.12% |
267,816
+256,260
| +2,218% | +$5.36M |
|
211
CVS Health
CVS
$137B
| $6.16M | 0.12% |
59,662
+5,632
| +10% | +$570K |
|
212
Neurocrine Biosciences
NBIX
$17.7B
| $6.16M | 0.12% |
155,000
-55,000
| -26% | -$1.97M |
|
213
Ralph Lauren
RL
$22.2B
| $6.13M | 0.12% |
46,639
-6,677
| -13% | -$989K |
|
214
Skyworks Solutions
SWKS
$9.06B
| $6.13M | 0.12% |
62,380
+55,380
| +791% | +$4.73M |
|
215
Delta Air Lines
DAL
$55.9B
| $6.12M | 0.12% |
136,000
+35,783
| +36% | +$1.66M |
|
216
Micron Technology
MU
$1.04T
| $6.12M | 0.12% |
225,387
-49,500
| -18% | -$1.48M |
|
|
PTLA
217
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $6.08M | 0.12% |
+160,000
| New | +$5.5M |
|
218
Bausch Health
BHC
$1.65B
| $6.07M | 0.12% |
30,576
+3,000
| +11% | +$532K |
|
219
Applied Materials
AMAT
$426B
| $6.07M | 0.12% |
268,772
+198,273
| +281% | +$4.75M |
|
|
CHK
220
DELISTED
Chesapeake Energy Corporation
CHK
| $6.07M | 0.12% |
2,141
-655
| -23% | -$2.31M |
|
221
Illinois Tool Works
ITW
$81.4B
| $6.06M | 0.12% |
62,390
+46,767
| +299% | +$4.51M |
|
|
RDUS
222
DELISTED
Radius Health, Inc.
RDUS
| $6.01M | 0.12% |
146,000
+81,000
| +125% | +$3.64M |
|
223
Honeywell
HON
$77.1B
| $5.97M | 0.12% |
63,666
+7,092
| +13% | +$649K |
|
|
HSP
224
DELISTED
HOSPIRA INC
HSP
| $5.95M | 0.12% |
67,688
+37,671
| +125% | +$2.95M |
|
225
PTC Therapeutics
PTCT
$6.37B
| $5.9M | 0.12% |
97,000
-3,000
| -3% | -$183K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2015 Portfolio in Review
As of Q1 2015, Candriam SCA held 683 positions worth $4.96B, up 3.8% from $4.78B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Candriam SCA's Q1 2015 filing shows 65 new, 262 increased, 255 reduced and 50 closed positions. Its largest new stake was TOWERS WATSON & CO COM STK CL A (DE): 96,485 shares worth $12.8M. The largest sale was KEURIG GREEN MTN INC, an estimated $32.8M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Financials and Technology.
- Candriam SCA's largest Q1 2015 buy was TOWERS WATSON & CO COM STK CL A (DE): 96,485 shares worth $12.8M.
- Candriam SCA added most to Amgen in Q1 2015, an estimated $53M increase.
- Candriam SCA's biggest Q1 2015 reduction was KEURIG GREEN MTN INC, cutting an estimated $32.8M.
- Candriam SCA fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q1 2015, selling an estimated $19.2M.
- Candriam SCA's ten largest holdings make up 16% of its $4.96B portfolio in Q1 2015.
- Candriam SCA opened 65 new positions and closed 50 in Q1 2015.
- Candriam SCA's portfolio value rose 3.8% quarter-over-quarter to $4.96B.
Based on Candriam SCA's 13F filing for Q1 2015, filed 27 Apr 2015.